文献速递类风湿关节炎脊柱关节炎系统性红斑狼疮

患者作为研究伙伴参与风湿病学研究:2023年文献综述

Involving patients as research partners in research in rheumatology: a literature review in 2023.
PubMed 文献 · RMD Open · 2023-11-23

该范围综述纳入截至2023年3月1日发表的80篇最新文献(40篇转化研究和40篇随机对照试验),覆盖类风湿关节炎、银屑病关节炎、系统性红斑狼疮和下肢骨关节炎四种疾病。结果显示40篇转化研究中无一篇报告患者研究伙伴参与,40篇随机对照试验中8篇(20%)报告参与,且参与主要限于研究设计阶段。作者认为患者研究伙伴在风湿病学转化研究和随机对照试验中代表性明显不足。

要点

  • 40篇转化研究中无一篇报告患者研究伙伴参与。
  • 40篇随机对照试验中8篇(20%)报告患者研究伙伴参与,其中75%为非企业资助。
  • 报告参与类型的6篇研究中,6篇参与研究设计或干预设计,2篇参与结果解读。

核心结论

  • 尽管全球倡导增加患者在研究中的参与,患者研究伙伴在风湿病学转化研究和随机对照试验中代表性明显不足。
  • 患者研究伙伴在研究中的有限参与凸显了现有建议与实际做法之间持续存在的差距。

研究设计与样本

  • 本研究为范围综述,纳入截至2023年3月1日发表的80篇最新文献,包括40篇转化研究和40篇随机对照试验。
  • 覆盖四种目标疾病:类风湿关节炎、银屑病关节炎、系统性红斑狼疮和下肢骨关节炎,每种疾病选取20篇论文,来源于风湿病学期刊和综合科学期刊。
  • 每篇论文评估患者研究伙伴的参与程度,分析为描述性分析。

主要发现

  • 40篇转化研究中,无一篇报告患者研究伙伴参与。
  • 40篇随机对照试验中,8篇(20%)报告患者研究伙伴参与;这些试验主要来自欧洲(75%)和北美(25%)。
  • 8篇试验中大多数(75%)为非企业资助。
  • 8篇研究中有6篇报告了患者研究伙伴参与类型:6篇报告参与研究设计或干预设计,其中2篇同时报告参与结果解读。
  • 报告患者研究伙伴数量的试验(占75%)均纳入至少2名患者研究伙伴。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The inclusion of patient research partners (PRPs) in research projects is increasingly recognised and recommended in rheumatology. The level of involvement of PRPs in translational research in rheumatology remains unknown, while in randomised clinical trials (RCTs), it has been reported to be 2% in 2020. Therefore, we aimed to assess the involvement of PRPs in recent translational studies and RCTs in rheumatology. METHODS: We conducted a scoping literature review of the 80 most recent articles (40 translational studies and 40 RCTs) from four target diseases: rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus and lower extremity osteoarthritis. We selected 20 papers from each disease, published up until 1 March 2023, in rheumatology and general scientific journals. In each paper, the extent of PRP involvement was assessed. Analyses were descriptive. RESULTS: Of 40 translational studies, none reported PRP involvement. Of 40 RCTs, eight studies (20%) reported PRP involvement. These trials were mainly from Europe (75%) and North America (25%). Most of them (75%) were non-industry funded. The type of PRP involvement was reported in six of eight studies: six studies reported PRP participation in the study design or design of the intervention and two of them in the interpretation of the results. All the trials reporting the number of PRPs (75%), involved at least two PRPs. CONCLUSION: Despite a worldwide movement advocating for increased patient involvement in research, PRPs in translational research and RCTs in rheumatology are significantly under-represented. This limited involvement of PRPs in research highlights a persistent gap between the existing recommendations and actual practice.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Elhai M, Benavent D, Aouad K, et al. Involving patients as research partners in research in rheumatology: a literature review in 2023. RMD Open. 2023. PMID: 37996123. doi:10.1136/rmdopen-2023-003566

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。